China's Sinopharm vaccine: how effective is it and where will it be rolled out?

China's Sinopharm Covid vaccine: how effective is it and where will it be rolled out?
Helen Davidson
© Provided by The Guardian
Photograph: Tingshu Wang/Reuters
Trials in the United Arab Emirates have shown that China’s Sinopharm vaccine has 86% efficacy. So what is the Chinese treatment, where is it being trialled and will it challenge the vaccines being developed in western countries?
© Photograph: Tingshu Wang/Reuters
Sinopharm is a state-owned Chinese pharmaceutical company and is trialling two Covid-19 vaccines in countries including UAe, Argentina and Morocco.
What is the Sinopharm vaccine?
Sinopharm Group is a state-owned pharmaceutical company with two vaccine candidates among China’s five experimental treatment in international final stage trials. The vaccines are not being trialled in China because the domestic prevalence of the virus is so low. Sinopharm’s vaccine and bioscience subsidiary is the China National Biotec Group Co Ltd (CNBG). Public statements about Sinopharm vaccines do not appear to clarify which of the two candidates are being discussed.

Related Keywords

Egypt ,Argentina ,Morocco ,China ,Peru ,United Arab Emirates ,Wuhan ,Hubei ,Bahrain ,Peruvian ,Chinese ,Terry Nolan ,Jamal Al Kaabi ,Wang Junzhi ,Astrazeneca ,Sinopharm Group ,Peter Doherty Institute ,Cnn ,China National Biotec Group Co Ltd ,Guardian Photograph ,Reuters Sinopharm ,எகிப்து ,அர்ஜெண்டினா ,மொராக்கோ ,சீனா ,பெரு ,ஒன்றுபட்டது அரபு அமீரகங்கள் ,பஹ்ரைன் ,பெருவியன் ,சீன ,டெர்ரி நோலன் ,ஜமால் அல் காபி ,பீட்டர் டோவர்டீ நிறுவனம் ,சின்ன ,சீனா தேசிய பயோடெக் குழு இணை லிமிடெட் ,பாதுகாவலர் புகைப்படம் ,